期刊文献+

Increased expression of the 20S proteasome in peripheral blood mononuclear cells of type 2 diabetic patients

Increased expression of the 20S proteasome in peripheral blood mononuclear cells of type 2 diabetic patients
下载PDF
导出
摘要 Objective To investigate the dynamic expression of the 20S proteasome in peripheral blood mononuclear cells(PBMCs)of type 2 diabetic patients without vascular complications.Methods PBMCs were prepared from 30 type 2 diabetic patients and 30 nondiabetic controls.The general indexes including weight,height and blood pressure were recorded.Fasting plasma glucose,fasting plasma insulin and glycosylated hemoglobin were measured.The protein level of the 20S proteasome was measured by Western blotting.The mRNA expression levels of the 20S proteasome β1,β2 and β5 subunits were detected by real-time PCR.Results Compared with that in the nondiabetic controls,the protein level of the 20S proteasome was significantly increased in the diabetic patients and was positively associated with glycosylated hemoglobin.Conclusion Type 2 diabetic patients without vascular complications have an increased 20S proteasome expression,the significance of which needs to be explored by further study. Objective To investigate the dynamic expression of the 20S proteasome in peripheral blood mononuclear cells(PBMCs)of type 2 diabetic patients without vascular complications.Methods PBMCs were prepared from 30 type 2 diabetic patients and 30 nondiabetic controls.The general indexes including weight,height and blood pressure were recorded.Fasting plasma glucose,fasting plasma insulin and glycosylated hemoglobin were measured.The protein level of the 20S proteasome was measured by Western blotting.The mRNA expression levels of the 20S proteasome β1,β2 and β5 subunits were detected by real-time PCR.Results Compared with that in the nondiabetic controls,the protein level of the 20S proteasome was significantly increased in the diabetic patients and was positively associated with glycosylated hemoglobin.Conclusion Type 2 diabetic patients without vascular complications have an increased 20S proteasome expression,the significance of which needs to be explored by further study.
出处 《Journal of Pharmaceutical Analysis》 SCIE CAS 2010年第4期255-259,共5页 药物分析学报(英文版)
关键词 type 2 diabetes mellitus ubiquitin-proteasome pathway 20S proteasome type 2 diabetes mellitus ubiquitin-proteasome pathway 20S proteasome
  • 相关文献

参考文献1

二级参考文献14

  • 1Dipankar Nandi,Pankaj Tahiliani,Anujith Kumar,Dilip Chandu.The ubiquitin-proteasome system[J].Journal of Biosciences.2006(1)
  • 2Nilofer Qureshi,Stefanie N. Vogel,Charles Way,Christopher J. Papasian,Asaf A. Qureshi,David C. Morrison.The proteasome[J].Immunologic Research.2005(3)
  • 3Peter J. Elliott,Thomas Matthias Zollner,Wolf-Henning Boehncke.Proteasome inhibition: a new anti-inflammatory strategy[J].Journal of Molecular Medicine.2003(4)
  • 4Julian Adams,Vito J. Palombella,Peter J. Elliott.Proteasome Inhibition: a New Strategy in Cancer Treatment[J].Investigational New Drugs.2000(2)
  • 5Cascio P,Hilton C,Kisselev AF,Rock KL,Goldberg AL.26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide[].EMBO Journal.2001
  • 6Gama V,Yoshida T,Gomez JA, et al.Involvement of the ubiquitin pathway in decreasing Ku70 levels in response to drug-induced apoptosis[].Experimental Cell Research.2006
  • 7Wang J,Dong X,Reeves WH.A model for Ku heterodimer assembly and interaction with DNA Implications for the function of Ku antigen[].Journal of Biological Chemistry.1998
  • 8Goldberg AL,Rock K.Not just research tools--proteasome inhibitors offer therapeutic promise[].Nature Medicine.2002
  • 9Kisselev AF,Goldberg AL.Proteasome inhibitors: from research tools to drug candidates[].Chemistry and Biology.2001
  • 10Adams J.The proteasome: structure, function, and role in the cell[].Cancer Treatment Reviews.2003

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部